Montelukast in asthmatic patients 6 years–14 years old with an FEV₁ > 75%

References

• Mannino DM, Homa DM, Akinbami LJ, et al. Surveillance for asthma – United States, 1980–1999. MMWR Surveill Summ 2002;29;51(1):1–13
   Google Scholar
• Juniper EF, Guyatt GH, Feeny DH, et al. Measuring quality of life in children with asthma. Qual Life Res 1996;5(1):35–46
   PubMed Web of Science ®Google Scholar
• National Asthma Education and Prevention Program. Expert panel report 2: guidelines for the diagnosis and management of asthma. In: NIH Publication No. 97–4051. Bethesda (MD): National Institutes of Health; 1997
   Google Scholar
• Global Initiative for Asthma. Pocket guide for asthma management and prevention. In: NIH Publication No. 96–3659B. Bethesda (MD): National Institutes of Health; 1998
   Google Scholar
• Boulet L-P, Becker A, Berube D, et al. Canadian asthma consensus report, 1999. Can Med Assoc J 1999;161\(Suppl 11):51–61 [review]
   Google Scholar
• Boulet L-P, Bai TR, Becker A, et al. What is new since the last (1999) Canadian asthma consensus guidelines? Can Respir J 2001;8(Suppl A):5A–27A
   Google Scholar
• Beasley R, Roche WR, Roberts JA, Holgate ST. Cellular events in the bronchi in mild asthma and after bronchoprovocation. Am Rev Respir Dis 1989;139:806–17
   PubMed Web of Science ®Google Scholar
• Lemanske RF. Origins and treatment of airway inflammation in childhood asthma. Ped Pulmonol Suppl 2001;21:17–25
   PubMedGoogle Scholar
• Djukanovic R. Airway inflammation in asthma and its consequences: implications for treatment in children and adults. J Allergy Clin Immunol 2002;109:S539–S548
   Google Scholar
• Holgate ST, Bradding P, Sampson AP. Leukotriene antagonists and synthesis inhibitors: new directions in asthma therapy. J Allergy Clin Immunol 1996;98:1–13
   Google Scholar
• Drazen JM, Israel E, O’Byrne PM. Treatment of asthma with drugs modifying the leukotriene pathway. New Engl J Med 1999;340:197–206
   PubMed Web of Science ®Google Scholar
• Knorr B, Matz J, Bernstein JA, et al. Montelukast for chronic asthma in 6- to 14-year-old children. J Am Med Assoc 1998;279:1181–6
   PubMed Web of Science ®Google Scholar
• Knorr B, Franchi LM, Bisgaard H, et al. Montelukast, a leukotriene receptor antagonist, for the treatment of persistent asthma in children aged 2 to 5 years. Pediatrics 2001;108 (3):E48
   PubMed Web of Science ®Google Scholar
• Reiss TF, Chervinsky P, Dockhorn RJ, et al. Montelukast, a once-daily leukotriene receptor antagonist, in the treatment of chronic asthma. Arch Intern Med 1998;158:1213–20
   PubMed Web of Science ®Google Scholar
• Kemp JP, Dockhorn RJ, Shapiro GG, et al. Montelukast once daily inhibits exercise-induced bronchoconstriction in 6- to 14-year-old children with asthma. J Pediatr 1998;133:424–8
   PubMed Web of Science ®Google Scholar
• Melo RE, Sole D, Naspitz CK. Exercise-induced bronchoconstriction in children: montelukast attenuates the immediate-phase and late phase responses. J Allergy Clin Immunol 2003;111:301–7
   Google Scholar
• Leff JA, Busse WW, Pearlman D, et al. Montelukast, a leukotriene-receptor antagonist, for the treatment of mild asthma and exercise-induced bronchoconstriction. New Engl J Med 1998;339(3):147–52
   PubMed Web of Science ®Google Scholar
• Bukstein DA, Luskin AT, Bernstein A. ‘Real World’ effectiveness of daily controller medicine in children with mild persistent asthma. Ann Allergy Asthma Immunol 2003;90:543–9
   PubMed Web of Science ®Google Scholar
• Barnes N, Wei LX, Reiss TF, et al. Analysis of montelukast in mild persistent asthmatic patients with near-normal lung function. Respir Med 2001;95:379–86
   PubMed Web of Science ®Google Scholar
• Karaman O, Sunneli L, Uzuner N, et al. Evaluation of montelukast in 8 to 14 year old children with mild persistent asthma and compared with inhaled corticosteroids. Allergol et Immunopathol 2004;32:21–7
   PubMedGoogle Scholar
• Santanello NC, Demuro-Mercon C, Davies G, et al. Validation of a pediatric asthma caregiver diary. J Allergy Clin Immunol 2000;106(5):861–6
   PubMed Web of Science ®Google Scholar
• Singulair® (montelukast sodium) tablets, chewable tablets, and oral granules. Merck & Co., Inc. Whitehouse Station, NJ, 2002
   Google Scholar
• Frieman, J, Chalmers TC, Smith H, Kuebler R. The importance of beta, the type II error and sample size in the design and interpretation of the randomized clinical trial. New Engl J Med 1978;299:690–4
   Google Scholar
• Juniper EF, Kline PA, Vanzieleghem MA, et al. Effect of long-term treatment with an inhaled corticosteroid (budesonide) on airway hyperresponsiveness and clinical asthma in nonsteroid-dependent asthmatics. Am Rev Respir Dis 1990;142(4):832–6
   PubMed Web of Science ®Google Scholar
• Wallin A, Sandström T, Söderberg M, et al. The effects of regular inhaled formoterol, budesonide, and placebo on mucosal inflammation and clinical indices in mild asthma. Am J Respir Crit Care Med 1999;159:79–86
   PubMed Web of Science ®Google Scholar
• Kemp JP, Minkwitz MC, Bonuccelli CM, Warren MS. Therapeutic effect of zafirlukast as monotherapy in steroid-naive patients with severe persistent asthma. Chest 1999;115(2):336–42
   PubMed Web of Science ®Google Scholar
• MacKenzie CA, Weinberg EG, Tabachnik E, et al. A placebo controlled trial of fluticasone propionate in asthmatic children. Eur J Pediatr 1993;152:856–60
   PubMed Web of Science ®Google Scholar
• Tinkelman DG, Reed CE, Nelson HS, Offord KP. Aerosol beclomethasone dipropionate compared with theophylline as primary treatment of chronic, mild to moderately severe asthma in children. Pediatrics 1993;92:64–77
   PubMed Web of Science ®Google Scholar
• Shapiro BB, Konig P. Cromolyn sodium: a review. Pharmaco-therapy 1985;5:156–70
   Google Scholar
• Strunk RC, Sternberg AL, Bacharier LB, et al. Nocturnal awakenings caused by asthma in children with mild-to-moderate asthma in the Childhood Asthma Management Program. J Allergy Clin Immunol 2002;110:395–403
   PubMed Web of Science ®Google Scholar
• Urschitz MS, Guenther A, Eggebrecht E, et al. Snoring, intermittent hypoxia and academic performance in primary school children. Am J Respir Crit Care Med 2003;168:464–8
   PubMed Web of Science ®Google Scholar
• Bousquet J, Chanez P, Lacoste JY, et al. Eosinophilic inflammation in asthma. New Engl J Med 1990;323:1033–9
   PubMed Web of Science ®Google Scholar
• Asthma: a follow-up statement from an international paediatric asthma consensus group. Arch Dis Child 1992;67: 240–8
   Google Scholar